A5208/OCTANE Optimal Combination Therapy After Nevirapine Exposure A Collaborative, Multicenter Trial Between the AIDS Clinical Trials Group (ACTG) and the Division of AIDS (DAIDS)-Sponsored Networks Sponsored by: The National Institute of Allergy and...March 21st, 2022
FiledMarch 21st, 2022Lynette Purdue, Pharm.D. NIAID/DAIDS/NIH Pharmaceutical Affairs Branch 6700B Rockledge Drive, Room 4107 Bethesda, MD 20892-7620 Phone: (301) 435-3744 FAX: (301) 402-1506 E-mail: lpurdue@niaid.nih.gov